Literature DB >> 27091322

Ulcerative Colitis Patients With Clostridium difficile are at Increased Risk of Death, Colectomy, and Postoperative Complications: A Population-Based Inception Cohort Study.

María E Negrón1,2, Ali Rezaie3, Herman W Barkema2, Kevin Rioux4, Jeroen De Buck2, Sylvia Checkley5, Paul L Beck4, Matthew Carroll6, Richard N Fedorak7, Levinus Dieleman7, Remo Panaccione4, Subrata Ghosh4, Gilaad G Kaplan1,4.   

Abstract

OBJECTIVES: Clostridium difficile (C. difficile) may worsen the prognosis of ulcerative colitis (UC). The objectives of this study were to: (i) validate the International Classification of Diseases-10 (ICD-10) code for C. difficile; (ii) determine the risk of C. difficile infection after diagnosis of UC; (iii) evaluate the effect of C. difficile infection on the risk of colectomy; and (iv) assess the association between C. difficile and postoperative complications.
METHODS: The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated by comparing ICD-10 codes for C. difficile with stool toxin tests. A population-based surveillance cohort of newly diagnosed UC patients living in Alberta, Canada were identified from 2003 to 2009 (n=1,754). The effect of a C. difficile infection on colectomy was modeled using competing risk survival regression after adjusting for covariates. The effect of a C. difficile infection on postoperative complications was assessed using a mixed effects logistic regression model.
RESULTS: The sensitivity, specificity, PPV, and NPV of the ICD-10 code for C. difficile were 82.1%, 99.4%, 88.4%, and 99.1%, respectively. The risk of C. difficile infection within 5 years of diagnosis with UC was 3.4% (95% confidence interval (CI): 2.5-4.6%). The risk of colectomy was higher among UC patients diagnosed with C. difficile (sub-hazard ratio (sHR)=2.36; 95% CI: 1.47-3.80). C. difficile increased the risk of postoperative complications (odds ratio=4.84; 95% CI: 1.28-18.35). C. difficile was associated with mortality (sHR=2.56 times; 95% CI: 1.28-5.10).
CONCLUSIONS: C. difficile diagnosis worsens the prognosis of newly diagnosed patients with UC by increasing the risk of colectomy, postoperative complications, and death.

Entities:  

Mesh:

Year:  2016        PMID: 27091322     DOI: 10.1038/ajg.2016.106

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  34 in total

1.  Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis.

Authors:  Gilaad G Kaplan; Ellen P McCarthy; John Z Ayanian; Joshua Korzenik; Richard Hodin; Bruce E Sands
Journal:  Gastroenterology       Date:  2008-01-10       Impact factor: 22.682

2.  Decreasing colectomy rates for ulcerative colitis: a population-based time trend study.

Authors:  Gilaad G Kaplan; Cynthia H Seow; Subrata Ghosh; Natalie Molodecky; Ali Rezaie; Gordon W Moran; Marie-Claude Proulx; James Hubbard; Anthony MacLean; Donald Buie; Remo Panaccione
Journal:  Am J Gastroenterol       Date:  2012-11-20       Impact factor: 10.864

3.  Clostridium difficile infection worsens the prognosis of ulcerative colitis.

Authors:  María E Negrón; Herman W Barkema; Kevin Rioux; Jeroen De Buck; Sylvia Checkley; Marie-Claude Proulx; Alexandra Frolkis; Paul L Beck; Levinus A Dieleman; Remo Panaccione; Subrata Ghosh; Gilaad G Kaplan
Journal:  Can J Gastroenterol Hepatol       Date:  2014 Jul-Aug

4.  Postoperative complications and mortality following colectomy for ulcerative colitis.

Authors:  Shanika de Silva; Christopher Ma; Marie-Claude Proulx; Marcelo Crespin; Belle S Kaplan; James Hubbard; Martin Prusinkiewicz; Andrew Fong; Remo Panaccione; Subrata Ghosh; Paul L Beck; Anthony Maclean; Donald Buie; Gilaad G Kaplan
Journal:  Clin Gastroenterol Hepatol       Date:  2011-07-30       Impact factor: 11.382

5.  Association of postoperative complications with hospital costs and length of stay in a tertiary care center.

Authors:  Nadia A Khan; Hude Quan; Jennifer M Bugar; Jane B Lemaire; Rollin Brant; William A Ghali
Journal:  J Gen Intern Med       Date:  2006-02       Impact factor: 5.128

6.  Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease.

Authors:  Ashwin N Ananthakrishnan; Emily L McGinley; Kia Saeian; David G Binion
Journal:  Inflamm Bowel Dis       Date:  2010-09-07       Impact factor: 5.325

Review 7.  Microbiota-mediated colonization resistance against intestinal pathogens.

Authors:  Charlie G Buffie; Eric G Pamer
Journal:  Nat Rev Immunol       Date:  2013-10-07       Impact factor: 53.106

8.  Epidemiology of Clostridium difficile colitis in hospitalized patients with inflammatory bowel diseases.

Authors:  Rocco Ricciardi; James W Ogilvie; Patricia L Roberts; Peter W Marcello; Thomas W Concannon; Nancy N Baxter
Journal:  Dis Colon Rectum       Date:  2009-01       Impact factor: 4.585

9.  Clostridium difficile ribotypes 027 and 106: clinical outcomes and risk factors.

Authors:  F Sundram; A Guyot; I Carboo; S Green; M Lilaonitkul; A Scourfield
Journal:  J Hosp Infect       Date:  2009-04-21       Impact factor: 3.926

10.  Clinical outcomes of patients with ulcerative colitis and co-existing Clostridium difficile infection.

Authors:  Daniela Jodorkovsky; Yuki Young; Maria T Abreu
Journal:  Dig Dis Sci       Date:  2009-03-03       Impact factor: 3.199

View more
  20 in total

1.  Treatment of recurrent Clostridium difficile infection using fecal microbiota transplantation in patients with inflammatory bowel disease.

Authors:  Krista M Newman; Kevin M Rank; Byron P Vaughn; Alexander Khoruts
Journal:  Gut Microbes       Date:  2017-01-19

2.  Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).

Authors:  L Clifford McDonald; Dale N Gerding; Stuart Johnson; Johan S Bakken; Karen C Carroll; Susan E Coffin; Erik R Dubberke; Kevin W Garey; Carolyn V Gould; Ciaran Kelly; Vivian Loo; Julia Shaklee Sammons; Thomas J Sandora; Mark H Wilcox
Journal:  Clin Infect Dis       Date:  2018-03-19       Impact factor: 9.079

3.  Impact of superimposed Clostridium difficile infection in Crohn's or ulcerative colitis flares in the outpatient setting.

Authors:  Patrícia Guedes Garcia; Liliana Andrade Chebli; Tarsila Campanha da Rocha Ribeiro; Pedro Duarte Gaburri; Fabio Heleno de Lima Pace; Kátia Valéria Bastos Dias Barbosa; Lívia Almeida Costa; William de Almeida Cruz; Isabelle Carvalho de Assis; Bernardo Rodriguez Mendes Moraes; Alexandre Zanini; Julio Maria Fonseca Chebli
Journal:  Int J Colorectal Dis       Date:  2018-06-21       Impact factor: 2.571

4.  Mortality Is Rare Following Elective and Non-elective Surgery for Ulcerative Colitis, but Mild Postoperative Complications Are Common.

Authors:  Joseph D Feuerstein; Thomas Curran; Michael Alosilla; Thomas Cataldo; Kenneth R Falchuk; Vitaliy Poylin
Journal:  Dig Dis Sci       Date:  2018-01-20       Impact factor: 3.199

5.  THAs Performed Within 6 Months of Clostridioides difficile Infection Are Associated with Increased Risk of 90-Day Complications.

Authors:  Scott J Douglas; Ethan A Remily; Oliver C Sax; Sahir S Pervaiz; Evan B Polsky; Ronald E Delanois
Journal:  Clin Orthop Relat Res       Date:  2021-12-01       Impact factor: 4.176

6.  First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus.

Authors:  Maryam Alkhatry; Ahmad Al-Rifai; Vito Annese; Filippos Georgopoulos; Ahmad N Jazzar; Ahmed M Khassouan; Zaher Koutoubi; Rahul Nathwani; Mazen S Taha; Jimmy K Limdi
Journal:  World J Gastroenterol       Date:  2020-11-21       Impact factor: 5.742

Review 7.  WSES-AAST guidelines: management of inflammatory bowel disease in the emergency setting.

Authors:  Belinda De Simone; Justin Davies; Elie Chouillard; Salomone Di Saverio; Frank Hoentjen; Antonio Tarasconi; Massimo Sartelli; Walter L Biffl; Luca Ansaloni; Federico Coccolini; Massimo Chiarugi; Nicola De'Angelis; Ernest E Moore; Yoram Kluger; Fikri Abu-Zidan; Boris Sakakushev; Raul Coimbra; Valerio Celentano; Imtiaz Wani; Tadeja Pintar; Gabriele Sganga; Isidoro Di Carlo; Dario Tartaglia; Manos Pikoulis; Maurizio Cardi; Marc A De Moya; Ari Leppaniemi; Andrew Kirkpatrick; Vanni Agnoletti; Gilberto Poggioli; Paolo Carcoforo; Gian Luca Baiocchi; Fausto Catena
Journal:  World J Emerg Surg       Date:  2021-05-11       Impact factor: 5.469

8.  Microbial Shifts and Shorter Time to Bowel Resection Surgery Associated with C. difficile in Pediatric Crohn's Disease.

Authors:  Jennifer Hellmann; Heidi Andersen; Lin Fei; Aaron Linn; Ramona Bezold; Kathleen Lake; Kimberly Jackson; Danielle Meyer; Kelsie Dirksing; Erin Bonkowski; Nicholas J Ollberding; David B Haslam; Lee Denson
Journal:  Inflamm Bowel Dis       Date:  2020-07-17       Impact factor: 7.290

9.  Predictors of High Health Care Utilization in Patients With Inflammatory Bowel Disease Within 1 Year of Establishing Specialist Care.

Authors:  Kenechukwu Chudy-Onwugaje; Alexander P Mamunes; David A Schwartz; Sara Horst; Raymond K Cross
Journal:  Inflamm Bowel Dis       Date:  2021-02-16       Impact factor: 5.325

10.  Decreased secondary faecal bile acids in children with ulcerative colitis and Clostridioides difficile infection.

Authors:  Sarah Rotondo-Trivette; Beibei Wang; Christopher Gayer; Riddhi Parsana; Yihui Luan; Fengzhu Sun; Sonia Michail
Journal:  Aliment Pharmacol Ther       Date:  2021-07-04       Impact factor: 9.524

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.